Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
Crossref DOI link: https://doi.org/10.1007/s11906-017-0728-z
Published Online: 2017-03-27
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Prosser, Hamish CG
Gregory, Cynthia
Hering, Dagmara
Hillis, Graham S
Perry, Greg
Rosman, Johan
Schultz, Carl
Thomas, Mark
Watts, Gerald F
Schlaich, Markus P
License valid from 2017-03-27